09:30 – 09:45

Registration

09:45 – 09:55

Welcome & Introduction

09:55 – 10:10

 

Opening Keynote:  Game Changer – Virus, Variants and Vaccines -The new post-pandemic age of Pharma!
As the world bears the brunt of the pandemic, the pharmaceutical industry has woken up to several new challenges. One such challenge is to develop a vaccine against the novel coronavirus as it continuously mutates. The keynote speaker in this session, by taking the example of the journey from Virus, Variants and Vaccines, will highlight how the pandemic has changed the norms of the industry forever and explore future trends.

Prof. S.S. Vasan, COVID-19 Project Leader, CSIRO (Australia) and Honorary Professor, University of York (UK)

10:15 – 10:30

 

Integrated Quality Management in Pharma

Phanikar Bhaskara Krishna, Head, Product Management Group, Caliber Technologies

10:35 – 10:50

 

Spotlight Session: Digital Transformation in Patient Care– Building a Resilient Enterprise

The resulting uncertain conditions due to the pandemic has put the pharma industry on hyper-drive mode. This is the only industry that is having to cater to demand and adapt to the changing consumer and market conditions on a regular basis. This session will explore how emerging technologies can help in providing solutions for the short-term but also long-term business solutions by weaving resilience against future shocks. This discussion will bring perspective on how global pharma is embracing digital transformation to enhance customer experience during this crisis:

  • Leveraging digital to enhance health outcomes and patient experiences to unlock growth and maximize impact across internal and external engagements
  • What are the main ways the global Covid-19 pandemic has transformed Pharma companies’ digital strategies?
  • Championing change within the organization towards a digital future
  • Driving digital innovation capabilities through partnerships
  • Re-imagining a hybrid commercialization model in the new normal

Rehan Khan, Managing Director, MSD Pharmaceuticals

10:55 – 11:45

CIO Panel: The Overhaul – From Raw Materials to Pharmacies 

Given the shifts that have taken place seemingly overnight in response to the immediate crisis, companies have to turn their attention to critical focus areas such as faster time to market, changing consumer behaviour and compliance with new regulations. This session, of, by and for the CIOs/CTOs/CDOs, will look at analysing functions and processes to understand how emerging technologies such as automation, AI can help bring down time to market. Several other facets of technology can help in varied processes such as sourcing raw materials, quicker manufacturing, quality control, batching, labelling and final delivery to point of sales.

Discussion Points:

  • The role of RPA, Automation across internal process including OCR etc
  • Smart batching and labelling using intelligent automation
  • Setting up smart ERP for end to end business insights or a collaborative connected planning approach
  • Modernising IT infrastructure
  • How IIoT is enabling smart manufacturing
  • Data security- endpoint security, threat intelligence, and cyberattack response

Featured Speakers:

  • Jitendra Mishra, VP Group CIO, Alembic Pharmaceuticals
  • Anjani Kumar, Chief Information Officer, Strides Pharma
  • Sekhar Surabhi, President & CEO, Caliber Technologies
  • Chakravarthi AVPS, Global Ambassador, World Packaging Organisation & Hon Advisor and Director on board – Pharmaceutical Export Promotion Council, Govt of India
  • Sreeji Gopinathan, Global Chief Information Officer, Lupin

Panel Chair:

  • Shirish Belapure, Senior Technical Advisor, Indian Pharmaceutical Alliance (IPA)

11:50 – 12:05

 

Case Study: Is AI the Silver Bullet in Drug R&D?

With world trying to deal with the crisis, it has greatly impacted drug research and development. As we navigate through our “New normal”, crucial questions must be answered to find out how AI can help. Hear exclusive insights from the industry expert leading the charge with AI in their organizations:

  • What progress has been made in the potential and foothold of AI in drug R&D over the last 12 months?
  • What recent applications of AI have been particularly pivotal in the industry’s progress?
  • How can AI help accelerate drug R&D through virtual trials, and what other applications does AI have against the Covid-19 pandemic?
  • What are the key challenges with leveraging and embedding AI, and how are we trying to address these?

Vishal Dhupar, Managing Director, South Asia, NVIDIA

12:10 – 12:40

Fire side Chat: Where are we now & what’s in the cards? # Digital Innovation in Pharma – Pandemic & Beyond!

Covid-19 has sent shockwaves through the world and has greatly impacted the way we function. Since the Coronavirus outbreak, pharmaceutical and medical devices companies have been struggling to conduct business as usual. As the virus continues to spread, all-sized laboratories realize the importance of providing digital tools to manage their teams, communicate with the healthcare professionals and monitor the patients
The discussion will dig into the fact that how well COVID-19 has uncovered a strong need for innovation and the adoption of digital tools, and quite successfully showcased how quickly the industry can embrace changes when it is pressured to do so:

  • How is the digital landscape continuing to change the pharmaceutical industry?
  • What do you see as being the biggest challenges and risks associated with IoT adoption in the pharma sector?
  • What did various organisations do to meet the fast-paced demands?
  • How will the regulatory landscape, policies and procedures continue to impact?
  • How is the digital landscape continuing to change the pharmaceutical industry?
  • Leveraging digital to enhance health outcomes and patient experiences to unlock growth and maximize impact across internal and external engagements
  • Need for Indian pharma companies to invest in R&D
  • Affordable innovation to better tackle global health emergencies

Featured Speakers:

  • Sudarshan Jain, Secretary General, Indian Pharmaceutical Alliance
  • Sanjeev Navangul, Managing Director & CEO, Bharat Serums
  • Rajaram Narayanan, Managing Director, Sanofi India

Panel Moderator:

  • Rahul Guha, Managing Director and Partner, BCG

12:45 – 12:55

 

Pharmaceutical Threat Landscape: Staying Ahead of Cyber Viruses

Vivek Srivastava, Regional Sales Director India & SAARC, CrowdStrike

13:00 – 13:15

Keynote: Understanding Disease States through Digital Sensors/Wearables for Patient Centric Drug Development

Dr Anand Subramony, Vice President, External Innovation & Novel Technologies, AstraZeneca

13:20 – 14:05

Leaders Panel: How technology is bringing patient centricity to life

The patient is the most important stakeholder in healthcare. All other healthcare stakeholders exist for the patient and must work only towards his benefit. Therefore, understanding what it means is the most crucial step.
This session with the senior leaders of the Indian pharma industry will focus on how pharmaceuticals are working to connect with their patients with the use of technology. It will cover essential questions such as:

– What is patient centricity? Why is it important?
– How does the digital growth enable patient centric companies and communication?
– Challenges, opportunities and strategies as future enablers for a patient centric approach

Featured Speakers:

  • Satish Reddy, Chairman, Dr. Reddy’s Laboratories and President, IPA
  • Dr. Murtaza Khorakiwala, Managing Director, Wockhardt
  • V Simpson Emmanuel, Managing Director & CEO, Roche Pharma India
  • Vani Manja, Managing Director, Boehringer Ingelheim India

Panel Moderator:

  • Vikas Bhadoria, Senior Partner, McKinsey

14:10 – 14:20

 

Virtual Twin Experience

Guillaume KERBOUL, Life Sciences Industry Value Expert Director, Dassault Systèmes

14:25 – 14:40

 

 

Standalone session: How Technology is Revolutionizing Clinical Trials- What’s next?
The session will focus on tech and how it can make clinical trials more effective,
by offering faster and deeper insights that determine the success of the trials.

  • AI and IOT: Preparing for the future of disruptive innovation and emerging technology
  • Best practices for working with digital data
  • Optimizing patient centricity in clinical trials through IoT and mobile applications:
  • Patient engagement tools and digital data collection
  • Leveraging machine learning and artificial intelligence to predict what is happening with consumers and patients
  • Data security considerations with IoT for clinical trials

Dr Chirag Trivedi, Clinical Study Unit Cluster Head – India-South East Asia & Past President – ISCR, Sanofi

14:45 – 14:55

 

Adopting AI and Machine Learning to unlock the full potential of Pharma

Manikandan Balasubramanian, Associate Partner, Intelligent Automation & Artificial Intelligence practice, EY LLP

15:00 – 15:10

 

Accelerate Digitalization in Pharma with Low Code Platforms

Venkanna Chowdary Manne, CEO and Founder, Amplelogic

15:10 – 16:00

Panel Discussion: Digital Transformation of Pharma Supply Chain & Lessons learnt from the Pandemic!
The entire world struggled with the supply chain disruption during the pandemic. The session will deliberate on the following topics:

  • How did the world dynamics change?
  • What has been India’s position?
  • What efforts have been made to achieve supply chain resilience globally and what were some of the challenges (e.g. higher costs)?
  • what strategies have been adopted by the Indian companies to de-risk themselves?
  • Where is India in its ambition to become globally preferred destination, especially from reshoring perspective (MNC executives can talk about the company preferences while selecting manufacturers / suppliers)?
  • What more is required from policy intervention perspective

Featured Speakers:

  • Prasad Deshpande, Global Head Supply Chain, ‎Biocon
  • Swapn Malpani, Joint President – Head Global Supply Chain, Cipla
  • Vickram Srivastava, Head of Planning – Global Supply Chain, Sun Pharma
  • Gagan Bharadwaj, Senior Vice President – Supply Chain, Intas Pharmaceuticals
  • Saurabh Gupta, Senior Vice President – Head Global Supply Chain, Lupin
  • Anand Garg, Vice President – Head India Supply Chain, Dr. Reddy’s Laboratories

Panel moderator:

  • Jaidev Rajpal, Partner, McKinsey
16:00-16:05 Vote of Thanks & Conference Ends